Cargando…

The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment

Detalles Bibliográficos
Autores principales:	Chen, Hao, Kondo, Masaaki, Horita, Nobuyuki, Takahashi, Kenichi, Kaneko, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670233/ https://www.ncbi.nlm.nih.gov/pubmed/38001605 http://dx.doi.org/10.3390/cancers15225346

Ejemplares similares

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer
por: Chen, Hao, et al.
Publicado: (2023)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Can proton pump inhibitors cause intestinal inflammation in children?
por: Kang, Ben
Publicado: (2019)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

Are proton pump inhibitors a double-edged sword in the treatment of Helicobacter pylori infection?
por: Ge, Ruiguang
Publicado: (2012)

Re-thinking the possible interaction between proton pump inhibitors and capecitabine
por: Jeong, Soo Hee, et al.
Publicado: (2022)

Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications
por: Shin, Cheol Min, et al.
Publicado: (2016)

Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?
por: Graham, David Y., et al.
Publicado: (2017)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
por: Sharma, Rakesh K, et al.
Publicado: (2010)

The potential interaction between clopidogrel and proton pump inhibitors: a systematic review
por: Lima, Joao Paulo de Aquino, et al.
Publicado: (2010)

Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?
por: Lee, Chansu, et al.
Publicado: (2016)

Proton pump inhibitors for the treatment of cancer in companion animals
por: Walsh, Megan, et al.
Publicado: (2015)

Cardiotoxicity Associated with Immune Checkpoint Inhibitors
por: Minegishi, Shintaro, et al.
Publicado: (2023)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
por: Wedemeyer, Ralph-Steven, et al.
Publicado: (2014)

The relationship between proton pump inhibitors and renal disease
por: Morschel, Carine Franco, et al.
Publicado: (2018)

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases
por: Gurbel, Paul A, et al.
Publicado: (2010)

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure
por: Raoul, J.L., et al.
Publicado: (2023)

Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
por: Miao, Jing, et al.
Publicado: (2023)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions.
por: Meyer, U. A.
Publicado: (1996)

Impedance pH Guided Approach to Proton Pump Inhibitor-refractory Non-erosive Reflux Disease
por: Cho, Yu Kyung
Publicado: (2014)

Do Proton Pump Inhibitor–refractory Laryngeal Symptoms Represent a True Acid-related Disease?
por: Hong, Kwon-Eui, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options
por: van Leeuwen, Roelof W. F., et al.
Publicado: (2017)

Genetic model selection for a case–control study and a meta-analysis
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Horita, Nobuyuki, et al.
Publicado: (2020)

Effect of Proton Pump Inhibitors on Colorectal Cancer
por: Sasaki, Takamitsu, et al.
Publicado: (2020)

Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs
por: Douglas, Ian J, et al.
Publicado: (2012)

Interaction between xylanase and a proton pump inhibitor on broiler chicken performance and gut function
por: González-Ortiz, Gemma, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m7ln8r0cmn57q0mqub300gu8eu